- Home
- CNK vs TARS Comparison
CNK vs TARS Comparison
Compare CNK & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNK
- TARS
- Stock Information
- Founded
- CNK 1984
- TARS 2016
- Country
- CNK United States
- TARS United States
- Employees
- CNK N/A
- TARS N/A
- Industry
- CNK Movies/Entertainment
- TARS Medicinal Chemicals and Botanical Products
- Sector
- CNK Consumer Discretionary
- TARS Health Care
- Exchange
- CNK Nasdaq
- TARS Nasdaq
- Market Cap
- CNK 3.1B
- TARS 2.8B
- IPO Year
- CNK 2007
- TARS 2020
- Fundamental
- Price
- CNK $26.96
- TARS $67.96
- Analyst Decision
- CNK Buy
- TARS Strong Buy
- Analyst Count
- CNK 11
- TARS 7
- Target Price
- CNK $35.09
- TARS $69.43
- AVG Volume (30 Days)
- CNK 3.5M
- TARS 605.4K
- Earning Date
- CNK 11-05-2025
- TARS 11-04-2025
- Dividend Yield
- CNK 1.20%
- TARS N/A
- EPS Growth
- CNK 86.03
- TARS N/A
- EPS
- CNK 1.92
- TARS N/A
- Revenue
- CNK $3,217,300,000.00
- TARS $295,521,000.00
- Revenue This Year
- CNK $7.13
- TARS $139.46
- Revenue Next Year
- CNK $7.56
- TARS $49.91
- P/E Ratio
- CNK $14.20
- TARS N/A
- Revenue Growth
- CNK 13.80
- TARS 254.45
- 52 Week Low
- CNK $23.12
- TARS $38.51
- 52 Week High
- CNK $36.28
- TARS $76.81
- Technical
- Relative Strength Index (RSI)
- CNK 50.53
- TARS 55.24
- Support Level
- CNK $26.01
- TARS $66.31
- Resistance Level
- CNK $27.44
- TARS $69.33
- Average True Range (ATR)
- CNK 0.97
- TARS 2.79
- MACD
- CNK 0.08
- TARS -0.97
- Stochastic Oscillator
- CNK 74.20
- TARS 23.11
About CNK Cinemark Holdings Inc Cinemark Holdings Inc.
Cinemark Holdings Inc is a geographically diverse operator in the motion picture exhibition industry in the United States. The company generates revenue from filmed entertainment box office receipts and concession sales, with additional revenue from screen advertising, screen rentals, and other revenue streams, such as transactional fees, vendor marketing promotions, studio trailer placements, meeting rentals, and electronic video games located in some of the theatres.
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.